ReviewHeliyon2023
Potentiality of homestead agroforestry for achieving sustainable development goals: Bangladesh perspectives.
Review in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Moringa-based homestead to achieve Sustainable Development Goals: A case study from Jaintiapur of Sylhet, Bangladesh.Heliyon · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Homestead agroforestry is one of the recognized agroforestry practices in Bangladesh. While the monoculture cropping system is enormously intensified, homestead agroforestry has added dimension to rapid economic growth. But despite having significance, homestead agroforestry is not gaining concern in further development. The study was done to bring this topic into focus by compiling the prospects of homestead agroforestry in Bangladesh by highlighting the significance and necessity. A secondary analysis was done by reviewing the findings to do this research. To collect paper keywords, "Bangladesh homestead agroforestry", "Homestead agroforestry practices", "Homestead agroforestry status", "Homestead biodiversity'', "Homestead and SDGs," "Dominant species," and "Home garden agroforestry system" were entered. Following the PRISMA framework, 337 papers were collected, among which 113 met the inclusion or eligibility criteria. The interrelated publications of homestead agroforestry with SDGs were assessed from the 113 shortlisted articles. The interrelated publications assessment on homestead agroforestry in the context of Sustainable Development Goals figured out that major research output was oriented towards no poverty (44%), decent work and economic growth (27%), zero hunger (20%), indicating its link to achieve SDGs from Bangladesh perspectives. The shortlisted articles were reviewed in the context of Sustainable Development Goals (SDGs), food security, livelihood improvement, environmental resources conservation, and dominant species coverage. Consequently, the dominant species were tabulated along with their respective coverages according to their uses. The study identified that in all localities of Bangladesh, Mango, Areca, Coconut, and Mahogany are the highly preferred dominant species, while Jackfruit, Acacia, and Banana also prevailed. Hence, the study concluded that homestead agroforestry has significant prospects in food security, livelihood improvement, and environmental resources conservation, and its contribution to achieving Sustainable Development Goals cannot be ignored. But homestead agroforestry system is exposed to vulnerability due to constraints. The systematic elimination of prevailing constraints can help in successfully executing sustainable development goals, and fruitful consequences can be derived by imposing potential concerns on this sector.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.